bioRxivNeuroscience
Chronic evoked seizures in young pre-symptomatic APP/PS1 mice induce serotonin changes and accelerate onset on Alzheimer's disease-related neurpathology
Aaron del Pozo, Kevin M. KnoxiD, Leanne M LehmanniD, Stephanie Davidson, S Rho, Suman JayadeviD, Melissa L. Barker‐HaliskiiD
Abstract
ObjectivePeople with early-onset Alzheimers disease (AD) are at elevated seizure risk. Further, chronic seizures in pre-symptomatic stages may disrupt serotonin pathway-related protein expression, precipitating the onset of AD-related pathology and burden of neuropsychiatric comorbidities. Methods2-3-month-old APP/PS1, PSEN2-N141I, and transgenic control mice were sham or corneal kindled for 2 weeks to model chronic seizures. Seizure-induced changes in glia, serotonin pathway proteins, and amyloid {beta} levels in hippocampus and prefrontal cortex were quantified. ResultsAPP/PS1 mice experienced worsened mortality versus kindled Tg-controls. APP/PS1 females were also more susceptible to chronic kindled seizures. These changes correlated with a marked downregulation of hippocampal tryptophan hydroxylase 2 and monoamine oxidase A protein expression compared to controls; these changes were not detected in PSEN2-N141I mice. Kindled APP/PS1 mice exhibited amyloid {beta} overexpression and glial overactivity without plaque deposition. PSEN2 protein expression was AD model-dependent. SignificanceSeizures evoked in pre-symptomatic APP/PS1 mice promotes premature mortality in the absence of pathological A{beta} deposition. Disruptions in serotonin pathway metabolism are associated with increased glial reactivity and PSEN2 downregulation without amyloid {beta} deposition. This study provides the first direct evidence that seizures occurring prior to amyloid {beta} plaque accumulation worsen disease burden in an AD genotype-specific manner. HighlightsO_LISeizures are a comorbidity in Alzheimers disease that may worsen disease burden. C_LIO_LIPathological overlap between both neurological disorders is understudied. C_LIO_LIYoung APP/PS1, but not PSEN2-N141I mice, have increased seizure-induced mortality. C_LIO_LISeizures reduce hippocampal serotonin pathway proteins only in young APP/PS1 mice. C_LIO_LIKindled young APP/PS1 mice have glial hyperactivity before amyloid {beta} accumulation. C_LI
- Citations
- 15
- FWCI
- 2.66
- Field percentile
- top 9%
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Alzheimer's disease-associated genotypes differentially influence chronic evoked seizure outcomes and antiseizure medicine activity in aged mice
Kevin M. Knox, Stephanie Davidson, … Melissa L. Barker‐Haliski·bioRxiv·Oct 6, 2024
- Chronic Seizures Induce Sex-Specific Cognitive Deficits with Loss of Presenilin 2 Function
Kevin M. Knox, Megan Beckman, … Melissa L. Barker‐Haliski·Experimental NeurologyPeer-reviewed·Jan 9, 2023
- Excitatory: inhibitory imbalance in Alzheimer's disease is exacerbated by seizures with attenuation after rapamycin treatment in 5XFAD mice.
Aaron J Barbour, Sarah Gourmaud, … F E Jensen·bioRxiv·Mar 2, 2023
- Anxiety-like but not despair-like behaviors are further aggravated by chronic mild stress in the early stages of APPswe/PS1dE9 transgenic mice
Jun-Ying Gao, Ying Chen, … Ming Xiao·bioRxiv·Oct 12, 2017
- Early astrocytic dysfunction is associated to mistuned synapses as well as anxiety and depressive-like behavior in the AppNL-F mouse model of Alzheimers disease
Benjamin Portal, Moa Södergren, … Maria Lindskog·Journal of Alzheimer s DiseasePeer-reviewed·Jul 4, 2024
- Early-life stress exposure impacts the hippocampal synaptic proteome in a mouse model of Alzheimer's disease: age- and pathology-dependent effects on mitochondrial proteins
Janssen M. Kotah, Mandy S. J. Kater, … Anikó Kőrösi·Alzheimer s & DementiaPeer-reviewed·Dec 6, 2023